Cannabis Use and Psychosis: From Risk to Treatment

Dates and Times

Start: 12/16/2025 11:00 AM
End: 12/16/2025 12:00 PM

Objectives

1. Learn about the epidemiological impact of high potency cannabis use at individual and population level
2. The interplay between high potency cannabis use and DNA in shaping risk for clinical psychosis
3. The interplay between cannabis use and childhood adversity in increasing risk of 1) clinical psychosis and 2) paranoia
4. The impact of Cannabis Use Disorder on the outcome of Clinical psychosis and treatment opportunities

Grand Round Files

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Psychology Continuing Education Accreditation

Stony Brook University Department of Psychiatry & Behavioral Health is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0241.